Spots Global Cancer Trial Database for pathologic processes
Every month we try and update this database with for pathologic processes cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid Tumors | NCT03510104 | Advanced Cancer Metastatic Canc... Neoplasms Neoplasm Metast... Neoplastic Proc... Pathologic Proc... | MRX-2843 | 18 Years - | Meryx, Inc. | |
| Maximizing Lymph Node Dissection on Fresh and Fixed Lung Cancer Resection Specimens | NCT06252129 | Lung Cancer Lymph Node Meta... Pathologic Proc... | Subjects underg... Control group | 18 Years - | Brigham and Women's Hospital | |
| Study of TRC102 in Combination With Pemetrexed in Cancer Patients | NCT00692159 | Neoplasm | TRC102 + pemetr... | 18 Years - | Tracon Pharmaceuticals Inc. | |
| A Prospective Study of Clinical Outcomes for the Pathwork Tissue of Origin Test | NCT01649453 | Neoplasm Metast... | Pathwork® Tissu... | 18 Years - | Cedar Associates LLC | |
| SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Metastases | NCT03694015 | Neoplasm Metast... Neoplastic Proc... Neoplasms Pathologic Proc... | SUPR VMAT | 18 Years - | British Columbia Cancer Agency | |
| Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis | NCT02913365 | Hemoptysis Haemoptysis Lung Disease Pneumonia Tuberculosis Bronchiectasis Respiratory Tra... Respiratory Tra... Bronchitis Mycobacterium I... Bronchial Disea... Pulmonary Hemor... Signs and Sympt... Signs and Sympt... Pathologic Proc... Mycosis Hemorrhage Lung Cancer Pulmonary Embol... Arteriovenous F... | 18 Years - | Université de Sherbrooke | ||
| Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS) | NCT01201811 | Myelodysplastic... | Azacitidine | 18 Years - | Celgene | |
| Endoscopic Assisted Electrochemotherapy in Addition to Neoadjuvant Treatment of Locally Advanced Rectal Cancer | NCT03040180 | Locally Advance... Electrochemothe... Neoadjuvant The... Down Staging | Electrochemothe... EndoVE | 18 Years - | Zealand University Hospital | |
| A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia | NCT02130557 | Leukemia, Myelo... | Bosutinib Imatinib | 18 Years - | Pfizer | |
| Vorasidenib Expanded Access Program | NCT05592743 | Glioma Recurrence Disease Attribu... Pathologic Proc... Neoplasms, Neur... Neuroectodermal... Neoplasms, Germ... Neoplasms by Hi... Neoplasms Neoplasms, Glan... Neoplasms, Nerv... | Vorasidenib | 12 Years - | Servier | |
| Methadone in Cystectomy Patients | NCT04475029 | Pain, Postopera... Postoperative C... Pathologic Proc... Bladder Cancer Pain Signs and Sympt... Neurologic Mani... Neurologic Symp... Side Effect of ... | Methadone Morphine | 18 Years - 110 Years | University of Aarhus | |
| Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors | NCT01177007 | Liver Neoplasms | TheraSphere, Yt... | 18 Years - | Yale University | |
| Methadone in Cystectomy Patients | NCT04475029 | Pain, Postopera... Postoperative C... Pathologic Proc... Bladder Cancer Pain Signs and Sympt... Neurologic Mani... Neurologic Symp... Side Effect of ... | Methadone Morphine | 18 Years - 110 Years | University of Aarhus | |
| Maximizing Lymph Node Dissection on Fresh and Fixed Lung Cancer Resection Specimens | NCT06252129 | Lung Cancer Lymph Node Meta... Pathologic Proc... | Subjects underg... Control group | 18 Years - | Brigham and Women's Hospital | |
| Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol) | NCT04373265 | Adrenocortical ... | Relacorilant Pembrolizumab | 18 Years - | Corcept Therapeutics | |
| Modulation of Breast Cancer Risk Biomarkers by High Dose Vitamin D | NCT01166763 | Breast Cancer | vitamin D3 | - 55 Years | University of Kansas Medical Center | |
| Lymphaticovenous Anastomosis as Treatment for Lymphedema | NCT05441943 | Breast Cancer L... Secondary Lymph... Iatrogenic Lymp... Lymphedema Lymphedema of U... Lymphedema Arm Lymphedema, Bre... Breast Neoplasm Neoplasms Breast Cancer Breast Diseases Lymphatic Disea... Skin Diseases Postoperative C... Pathologic Proc... Anastomose Surgery Surgical; Lymph... Postmastectomy ... Postmastectomy ... Postmastectomy ... Postmastectomy ... | Lymphovenous an... | 18 Years - | Odense University Hospital | |
| ASPIRIN Trial Belgium | NCT03464305 | Colon Cancer | acetylsalicylic... Placebo | 45 Years - | University Hospital, Antwerp | |
| Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid Tumors | NCT03510104 | Advanced Cancer Metastatic Canc... Neoplasms Neoplasm Metast... Neoplastic Proc... Pathologic Proc... | MRX-2843 | 18 Years - | Meryx, Inc. | |
| Lymphaticovenous Anastomosis as Treatment for Lymphedema | NCT05441943 | Breast Cancer L... Secondary Lymph... Iatrogenic Lymp... Lymphedema Lymphedema of U... Lymphedema Arm Lymphedema, Bre... Breast Neoplasm Neoplasms Breast Cancer Breast Diseases Lymphatic Disea... Skin Diseases Postoperative C... Pathologic Proc... Anastomose Surgery Surgical; Lymph... Postmastectomy ... Postmastectomy ... Postmastectomy ... Postmastectomy ... | Lymphovenous an... | 18 Years - | Odense University Hospital | |
| Endoscopic Assisted Electrochemotherapy in Addition to Neoadjuvant Treatment of Locally Advanced Rectal Cancer | NCT03040180 | Locally Advance... Electrochemothe... Neoadjuvant The... Down Staging | Electrochemothe... EndoVE | 18 Years - | Zealand University Hospital | |
| A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia | NCT02130557 | Leukemia, Myelo... | Bosutinib Imatinib | 18 Years - | Pfizer | |
| Vorasidenib Expanded Access Program | NCT05592743 | Glioma Recurrence Disease Attribu... Pathologic Proc... Neoplasms, Neur... Neuroectodermal... Neoplasms, Germ... Neoplasms by Hi... Neoplasms Neoplasms, Glan... Neoplasms, Nerv... | Vorasidenib | 12 Years - | Servier |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
